Dermatitis Herpetiformis and Celiac Disease

Overview / Definition Dermatitis Herpetiformis (DH) is a chronic, autoimmune skin disorder characterized by vesicular eruptions and intense pruritus. It is strongly associated with Celiac Disease (CD), a condition where ingestion of gluten leads to damage in the small intestine. Epidemiology DH has a prevalence of approximately 1 in 10,000 individuals in the general population, with a higher incidence in individuals with CD. It predominantly affects adults, particularly those aged 30 to 40 years, and shows a slight male predominance. Incidence is higher in Northern European populations. Up to 80% of patients with DH may have underlying Celiac Disease. Pathophysiology / Mechanism The pathophysiology of DH involves an autoimmune response triggered by gluten ingestion. In genetically predisposed individuals, gluten peptides lead to the production of antibodies against tissue transglutaminase (tTG), resulting in skin manifestations. IgA antibodies are formed against epidermal transglutaminase. Complement activation leads to dermal-epidermal junction damage. Clinical Presentation Patients with DH typically present with symmetrical clusters of papulovesicular lesions located on extensor surfaces such as elbows, knees, and the scalp. Lesions may also involve the buttocks and back. Lesions are intensely pruritic and may become excoriated. Chronic cases may lead to post-inflammatory hyperpigmentation. Diagnosis / Workup The diagnosis of DH is primarily clinical but is confirmed through skin biopsy and serological testing. Skin biopsy should be performed on intact vesicles, revealing a characteristic granular IgA deposition at the dermal-epidermal junction. Serological tests for anti-tTG IgA and anti-endomysial antibodies are also significant. Duodenal biopsy may be performed to assess for associated Celiac Disease. Treatment / Management The cornerstone of treatment for DH is a strict gluten-free diet, which helps resolve skin lesions and prevent recurrences. In cases where